Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent

Saved in:
Bibliographic Details
Published in:Haemophilia : the official journal of the World Federation of Hemophilia 2016-09, Vol.22 (5), p.e459-e461
Main Authors: Takedani, H., Hirose, J., Minamoto, F., Kubota, M., Kinkawa, J., Noguchi, M.
Format: Article
Language:English
Subjects:
Adolescent
Antibodies, Neutralizing - blood
Blood Coagulation Factors - therapeutic use
Blood Coagulation Tests
Coagulants - therapeutic use
Factor VIIa - metabolism
Factor VIIa - therapeutic use
Factor X - metabolism
Factor X - therapeutic use
Hemophilia B - drug therapy
Hemophilia B - pathology
Hemorrhage - prevention & control
Humans
Male
Orthopedic Procedures
Recombinant Proteins - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3
cites cdi_FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3
container_end_page e461
container_issue 5
container_start_page e459
container_title Haemophilia : the official journal of the World Federation of Hemophilia
container_volume 22
creator Takedani, H.
Hirose, J.
Minamoto, F.
Kubota, M.
Kinkawa, J.
Noguchi, M.
description
doi_str_mv 10.1111/hae.13029
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1822469550</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1822469550</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3</originalsourceid><addsrcrecordid>eNp1kE9P2zAYh61p04Buh32BycdxSPGfxnaOqBSYxEaROu1oOfabxixNgp2o9NtjCHCbL_b76vk9kn8IfaNkTtM5qw3MKSes-ICOKRd5xnIqPj6_c5opRsUROonxnhDKGRGf0RGTi1wIyY-R_mXuu4C7MNRdb8B5i-MYthAOuEp7g5N71_W1b7zBvRk8tAPe-6HGvq196YcuRDxG324T28Iel4fexGneJvYL-lSZJsLX13uG_lyuNsvr7Ob26ufy_CazXPAiUwtm7YKLklWldM5VzrICJHOWMEUIs0LJwhBBQVLlcuNUQSSUCgwTVFnHZ-jH5O1D9zBCHPTORwtNY1roxqipYmwhijwnCT2dUBu6GANUug9-Z8JBU6Kf-9Tpz_qlz8R-f9WO5Q7cO_lWYALOJmDvGzj836Svz1dvymxK-DjA43vChH86CWWu__6-0uuLYkPXcqnv-BM9q48Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1822469550</pqid></control><display><type>article</type><title>Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Takedani, H. ; Hirose, J. ; Minamoto, F. ; Kubota, M. ; Kinkawa, J. ; Noguchi, M.</creator><creatorcontrib>Takedani, H. ; Hirose, J. ; Minamoto, F. ; Kubota, M. ; Kinkawa, J. ; Noguchi, M.</creatorcontrib><identifier>ISSN: 1351-8216</identifier><identifier>EISSN: 1365-2516</identifier><identifier>DOI: 10.1111/hae.13029</identifier><identifier>PMID: 27456673</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Antibodies, Neutralizing - blood ; Blood Coagulation Factors - therapeutic use ; Blood Coagulation Tests ; Coagulants - therapeutic use ; Factor VIIa - metabolism ; Factor VIIa - therapeutic use ; Factor X - metabolism ; Factor X - therapeutic use ; Hemophilia B - drug therapy ; Hemophilia B - pathology ; Hemorrhage - prevention &amp; control ; Humans ; Male ; Orthopedic Procedures ; Recombinant Proteins - therapeutic use</subject><ispartof>Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.e459-e461</ispartof><rights>2016 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3</citedby><cites>FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27456673$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takedani, H.</creatorcontrib><creatorcontrib>Hirose, J.</creatorcontrib><creatorcontrib>Minamoto, F.</creatorcontrib><creatorcontrib>Kubota, M.</creatorcontrib><creatorcontrib>Kinkawa, J.</creatorcontrib><creatorcontrib>Noguchi, M.</creatorcontrib><title>Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent</title><title>Haemophilia : the official journal of the World Federation of Hemophilia</title><addtitle>Haemophilia</addtitle><subject>Adolescent</subject><subject>Antibodies, Neutralizing - blood</subject><subject>Blood Coagulation Factors - therapeutic use</subject><subject>Blood Coagulation Tests</subject><subject>Coagulants - therapeutic use</subject><subject>Factor VIIa - metabolism</subject><subject>Factor VIIa - therapeutic use</subject><subject>Factor X - metabolism</subject><subject>Factor X - therapeutic use</subject><subject>Hemophilia B - drug therapy</subject><subject>Hemophilia B - pathology</subject><subject>Hemorrhage - prevention &amp; control</subject><subject>Humans</subject><subject>Male</subject><subject>Orthopedic Procedures</subject><subject>Recombinant Proteins - therapeutic use</subject><issn>1351-8216</issn><issn>1365-2516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kE9P2zAYh61p04Buh32BycdxSPGfxnaOqBSYxEaROu1oOfabxixNgp2o9NtjCHCbL_b76vk9kn8IfaNkTtM5qw3MKSes-ICOKRd5xnIqPj6_c5opRsUROonxnhDKGRGf0RGTi1wIyY-R_mXuu4C7MNRdb8B5i-MYthAOuEp7g5N71_W1b7zBvRk8tAPe-6HGvq196YcuRDxG324T28Iel4fexGneJvYL-lSZJsLX13uG_lyuNsvr7Ob26ufy_CazXPAiUwtm7YKLklWldM5VzrICJHOWMEUIs0LJwhBBQVLlcuNUQSSUCgwTVFnHZ-jH5O1D9zBCHPTORwtNY1roxqipYmwhijwnCT2dUBu6GANUug9-Z8JBU6Kf-9Tpz_qlz8R-f9WO5Q7cO_lWYALOJmDvGzj836Svz1dvymxK-DjA43vChH86CWWu__6-0uuLYkPXcqnv-BM9q48Y</recordid><startdate>201609</startdate><enddate>201609</enddate><creator>Takedani, H.</creator><creator>Hirose, J.</creator><creator>Minamoto, F.</creator><creator>Kubota, M.</creator><creator>Kinkawa, J.</creator><creator>Noguchi, M.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201609</creationdate><title>Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent</title><author>Takedani, H. ; Hirose, J. ; Minamoto, F. ; Kubota, M. ; Kinkawa, J. ; Noguchi, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Antibodies, Neutralizing - blood</topic><topic>Blood Coagulation Factors - therapeutic use</topic><topic>Blood Coagulation Tests</topic><topic>Coagulants - therapeutic use</topic><topic>Factor VIIa - metabolism</topic><topic>Factor VIIa - therapeutic use</topic><topic>Factor X - metabolism</topic><topic>Factor X - therapeutic use</topic><topic>Hemophilia B - drug therapy</topic><topic>Hemophilia B - pathology</topic><topic>Hemorrhage - prevention &amp; control</topic><topic>Humans</topic><topic>Male</topic><topic>Orthopedic Procedures</topic><topic>Recombinant Proteins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takedani, H.</creatorcontrib><creatorcontrib>Hirose, J.</creatorcontrib><creatorcontrib>Minamoto, F.</creatorcontrib><creatorcontrib>Kubota, M.</creatorcontrib><creatorcontrib>Kinkawa, J.</creatorcontrib><creatorcontrib>Noguchi, M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takedani, H.</au><au>Hirose, J.</au><au>Minamoto, F.</au><au>Kubota, M.</au><au>Kinkawa, J.</au><au>Noguchi, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent</atitle><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle><addtitle>Haemophilia</addtitle><date>2016-09</date><risdate>2016</risdate><volume>22</volume><issue>5</issue><spage>e459</spage><epage>e461</epage><pages>e459-e461</pages><issn>1351-8216</issn><eissn>1365-2516</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>27456673</pmid><doi>10.1111/hae.13029</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1351-8216
ispartof Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.e459-e461
issn 1351-8216
1365-2516
language eng
recordid cdi_proquest_miscellaneous_1822469550
source Wiley-Blackwell Read & Publish Collection
subjects Adolescent
Antibodies, Neutralizing - blood
Blood Coagulation Factors - therapeutic use
Blood Coagulation Tests
Coagulants - therapeutic use
Factor VIIa - metabolism
Factor VIIa - therapeutic use
Factor X - metabolism
Factor X - therapeutic use
Hemophilia B - drug therapy
Hemophilia B - pathology
Hemorrhage - prevention & control
Humans
Male
Orthopedic Procedures
Recombinant Proteins - therapeutic use
title Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A44%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Major%20orthopaedic%20surgery%20for%20a%20haemophilia%20patient%20with%20inhibitors%20using%20a%20new%20bypassing%20agent&rft.jtitle=Haemophilia%20:%20the%20official%20journal%20of%20the%20World%20Federation%20of%20Hemophilia&rft.au=Takedani,%20H.&rft.date=2016-09&rft.volume=22&rft.issue=5&rft.spage=e459&rft.epage=e461&rft.pages=e459-e461&rft.issn=1351-8216&rft.eissn=1365-2516&rft_id=info:doi/10.1111/hae.13029&rft_dat=%3Cproquest_cross%3E1822469550%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3639-842cc436b2fb7dddfdc29e72dc028002c6879a061e718d5ad8907eb8ea2618cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1822469550&rft_id=info:pmid/27456673&rfr_iscdi=true